Category
Pharmaceuticals & Healthcare Products
186 posts · page 2 of 19
Pharmaceuticals & Healthcare Products
Government proposals to ease clinical trial rules and what it means for R&D and innovation
New rules could boost innovation in clinical trials significantly.
Pharmaceuticals & Healthcare Products
Global companies setting up tech innovation centres in India and what it means for R&D
Global firms are boosting R&D by launching tech hubs in India.
Pharmaceuticals & Healthcare Products
Challenges and volatility in pharma stocks in H1 2025 and the impact on investor sentiment
Pharma stocks faced turmoil, shaking investor confidence.
Pharmaceuticals & Healthcare Products
The impact of pharma-grade sugar export policies on domestic supply and global trade
Pharma-grade sugar policies reshape markets and trade dynamics.
Pharmaceuticals & Healthcare Products
India’s dependence on imported APIs and strategies for boosting local manufacturing
India seeks to reduce reliance on imported APIs through local strategies.
Pharmaceuticals & Healthcare Products
Adoption of Indian Pharmacopoeia by international markets and its significance for trade
Indian Pharmacopoeia boosts global trade in pharmaceuticals.
Pharmaceuticals & Healthcare Products
Large acquisitions in Indian pharma and what consolidation means for competition and scale
Mergers in Indian pharma reshape competition and market dynamics.
Pharmaceuticals & Healthcare Products
State-level pharma and medical device policies and their role in attracting investment
State policies shape the future of pharma investments significantly.
Pharmaceuticals & Healthcare Products
Policy environment around medical devices and incentives for growth
Navigating policies can fuel medical device innovation and growth.
Pharmaceuticals & Healthcare Products
Pricing pressures versus value growth in therapy segments such as cardiac and diabetes
Balancing pricing pressures with value growth in therapies.